{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:28:37Z","timestamp":1782700117722,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.contraception.2022.01.017","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T10:50:30Z","timestamp":1643971830000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics\u2730,\u2730\u2730"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-3406","authenticated-orcid":false,"given":"Na'amah","family":"Razon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlali","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2853-9051","authenticated-orcid":false,"given":"Sarah","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-576X","authenticated-orcid":false,"given":"Lisa","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-717X","authenticated-orcid":false,"given":"Alison Byrne","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7686-5754","authenticated-orcid":false,"given":"Rachel","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dehlendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2022.01.017_bib0001","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability and future directions","volume":"183","author":"Newhall","year":"2000","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.contraception.2022.01.017_bib0002","first-page":"1","article-title":"Abortion surveillance - United States, 2011","volume":"63","author":"Pazol","year":"2014","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2022.01.017_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6907a1","article-title":"Abortion surveillance \u2014 United States, 2018","volume":"69","author":"Kortsmit","year":"2020","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2022.01.017_bib0004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2105\/AJPH.2012.301119","article-title":"It is time to integrate abortion into primary care","volume":"103","author":"Yanow","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2022.01.017_bib0005","unstructured":"Jones RK, Witwer E, Jerman J. Abortion Incidence and Service Availability the United States, 2017. New York: 2019. https:\/\/doi.org\/Abortion Incidence and Service Availability in the United States, 2017."},{"key":"10.1016\/j.contraception.2022.01.017_bib0006","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pop.2018.07.010","article-title":"Providing abortion services in the primary care setting","volume":"45","author":"Amico","year":"2018","journal-title":"Prim Care"},{"issue":"2","key":"10.1016\/j.contraception.2022.01.017_bib0007","article-title":"Breaking the silence in the primary care office: patients\u2019 attitudes toward discussing abortion during contraceptive counseling","volume":"16","author":"Dianat","year":"2020","journal-title":"Contraception X"},{"key":"10.1016\/j.contraception.2022.01.017_bib0008","series-title":"The state of primary care in the United States: a chartbook of facts and statistics","author":"Petterson","year":"2018"},{"key":"10.1016\/j.contraception.2022.01.017_bib0009","first-page":"1669","article-title":"The United States relies on family physicians unlike any other specialty","volume":"63","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.contraception.2022.01.017_bib0010","first-page":"706","article-title":"Postgraduate experiences with an advanced reproductive health and abortion training and leadership program","volume":"49","author":"Block","year":"2017","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0011","first-page":"204","article-title":"Benefits of comprehensive reproductive health education in family medicine residency","volume":"40","author":"Nothnagle","year":"2008","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0012","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3122\/jabfm.2013.06.120248","article-title":"Management of early pregnancy failure and induced abortion by family medicine educators","volume":"26","author":"Herbitter","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0013","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3122\/jabfm.2008.02.070158","article-title":"Patient attitudes toward early abortion services in the family medicine clinic","volume":"21","author":"Rubin","year":"2008","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0014","first-page":"184","article-title":"Abortion training in three family medicine programs: resident and patient outcomes","volume":"39","author":"Paul","year":"2007","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1370\/afm.1051","article-title":"Early abortion in family medicine: clinical outcomes","author":"Bennett","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0016","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10995-010-0722-4","article-title":"Women's preferences for the location of abortion services: a pilot study in two Chicago clinics","volume":"16","author":"Logsdon","year":"2012","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.contraception.2022.01.017_bib0017","first-page":"493","article-title":"Barriers and enablers to becoming abortion providers","volume":"44","author":"Greenberg","year":"2017","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0018","first-page":"180","article-title":"A long-term evaluation of a required reproductive health training rotation with opt-out provisions for family medicine residents","volume":"45","author":"Goodman","year":"2013","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.contraception.2019.05.011","article-title":"Intention to provide abortion upon completing family medicine residency and subsequent abortion provision: a 5-year follow-up survey","volume":"100","author":"Srinivasulu","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0020","first-page":"337","article-title":"Integrating abortion training into family medicine residency programs","volume":"39","author":"Dehlendorf","year":"2007","journal-title":"Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0021","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2105\/AJPH.2008.136325","article-title":"Medical liability insurance as a barrier to the provision of abortion services in family medicine","volume":"98","author":"Dehlendorf","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2022.01.017_bib0022","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMsb1612526","article-title":"Sixteen years of overregulation: time to unburden mifeprex","volume":"376","author":"ElG","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.contraception.2021.04.017","article-title":"US clinicians\u2019 perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care","volume":"104","author":"Srinivasulu","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0036","unstructured":"U.S Food and Drug Administration. \u201cMifeprex (mifepristone) Information.\u201d Accessed: December 17, 2021. Available: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/mifeprex-mifepristone-information."},{"key":"10.1016\/j.contraception.2022.01.017_bib0024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","article-title":"The theory of planned behavior","volume":"50","author":"Ajzen","year":"1991","journal-title":"Organ Behav Hum Decis Process"},{"key":"10.1016\/j.contraception.2022.01.017_bib0025","doi-asserted-by":"crossref","unstructured":"Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. 2005. https:\/\/doi.org\/10.1177\/1049732305276687.","DOI":"10.1177\/1049732305276687"},{"key":"10.1016\/j.contraception.2022.01.017_bib0026","author":"Razon","year":"2022","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2015.06.016","article-title":"Aligning mifepristone regulation with evidence: Driving policy change using 15 years of excellent safety data","volume":"92","author":"Cleland","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.contraception.2021.04.025","article-title":"The mifepristone REMS: a needless and unlawful barrier to care","volume":"104","author":"Kaye","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.contraception.2021.04.002","article-title":"Mifepristone restrictions and primary care: breaking the cycle of stigma through a learning collaborative model in the United States","volume":"104","author":"Calloway","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0031","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2021.04.026","article-title":"Family medicine provision of online medication abortion in three US states during COVID-19","volume":"104","author":"Godfrey","year":"2021","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.contraception.2022.01.017_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.contraception.2022.01.017_bib0033","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1370\/afm.2562","article-title":"Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study","volume":"18","author":"Munro","year":"2020","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.contraception.2022.01.017_bib0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2020.04.012","article-title":"Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services","volume":"102","author":"Yalahow","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.01.017_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1139\/facets-2020-0019","article-title":"How did the introduction of mifepristone impact the availability of abortion care in Ottawa? a qualitative study with abortion patients","volume":"5","author":"LaRoche","year":"2020","journal-title":"Facets"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422000270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:20:47Z","timestamp":1757881247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782422000270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"alternative-id":["S0010782422000270"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2022.01.017","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics\u2730,\u2730\u2730","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2022.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}